Financial Data and Key Metrics Changes - Total sales increased by 8% for the quarter, with core operating profit up 11% and core earnings per share up 14% to 55p [3][4] - Cash generation for the year so far is £6.3 billion, supporting growth investments and shareholder returns, including a dividend of 16p for the quarter [4][36] - Operating margin improved by 90 basis points in the quarter, driven by SG&A margin improvement [38] Business Line Data and Key Metrics Changes - Specialty medicines sales grew by 16%, with significant contributions from oncology (up 39%) and respiratory immunology (up 15%) [10][12] - HIV portfolio delivered 12% growth, primarily driven by long-acting injectables [21] - Vaccine sales increased by 2%, with strong demand for Shingrix, particularly in Europe [29] Market Data and Key Metrics Changes - In the U.S., Shingrix penetration is now at 43% of the eligible older adult population, with international sales accounting for around 70% of global Shingrix sales [30] - The oncology portfolio is expected to be a material growth driver, with Glenrep approved in eight markets [16][18] Company Strategy and Development Direction - The company is focused on investing for growth, with a pipeline of 15 scale opportunities expected to launch before 2031 [5][7] - Continued emphasis on business development to expand the pipeline, particularly in oncology and respiratory [6][84] - The company is committed to optimizing supply capacity and investing $30 billion in R&D and advanced manufacturing in the U.S. over the next five years [6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver on long-term commitments for growth, with an upgraded guidance for the year [8][42] - The company remains cautious about the near-term outlook for vaccines in the U.S. but is optimistic about long-term prospects [33] Other Important Information - The company has secured four FDA approvals this year and expects a fifth before year-end [4] - The company is upgrading its full-year sales expectations from 3-5% to 6-7% [42] Q&A Session Summary Question: Revenue gap between market expectations and GSK's target for 2031 - Management acknowledged the gap and highlighted underappreciated assets in oncology and respiratory as key areas for growth [51][54] Question: Future strategy updates - Management indicated that more details on the strategy would be provided at the full-year results, with confidence in achieving the £40 billion target by 2031 [52][58] Question: Shingrix growth expectations - Management confirmed that growth in Europe is expected to continue, with a focus on expanding immunization rates [60][66] Question: Investment in R&D and operational expenses - Management confirmed that R&D investment will continue to grow ahead of sales, with significant investments in new product launches [68] Question: Updates on Glenrep and Depamokimab - Management shared insights on the early experiences with Glenrep in Europe and the competitive landscape for Depamokimab, emphasizing the potential for both products [72][76]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $470 million, with contribution ex-TAC increasing to $288 million, reflecting a year-over-year tailwind from foreign currencies of $6 million [18][22] - Adjusted EBITDA was $105 million, up 28% year over year, resulting in an adjusted EBITDA margin of 36%, up 500 basis points year over year [21][22] - Net income improved to $40 million, with diluted earnings per share of $0.70 and adjusted diluted EPS of $1.31, up 36% year over year [23][24] Business Line Data and Key Metrics Changes - In performance media, revenue was $403 million, with contribution ex-TAC at $222 million, up 5% at constant currency [18][19] - Retail media revenue was $67 million, with contribution ex-TAC growing 11% at constant currency, driven by strong on-site retail media performance [21][22] - Media spend in retail media grew 26% year over year, with over 4,100 brands participating [12][21] Market Data and Key Metrics Changes - Travel was the fastest-growing vertical, up 24%, while fashion saw an 11% decline [20] - Media spend growth was noted in Asia-Pac and EMEA, with softer but improving trends in the U.S. [19] Company Strategy and Development Direction - The company is evolving into a diversified, multi-channel platform, with about 85% of media spend now outside of desktop display [5][6] - Focus on agentic AI and partnerships with AI platforms to enhance product recommendations and shopping experiences [6][8] - Plans to re-domicile to Luxembourg and list ordinary shares directly on Nasdaq to enhance capital management flexibility [16][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business strategy and the ability to capture shifts in commerce and advertising [17][29] - Anticipated lower revenue in Q4 due to specific client scope changes, but underlying growth in retail media is expected to be strong [26][28] - The company expects contribution ex-TAC to grow 3% to 4% year over year at constant currency for 2025 [25][26] Other Important Information - The company closed the quarter with $811 million in total liquidity and no long-term debt, allowing for strategic flexibility [24] - The introduction of the Commerce GO solution is expected to drive higher spend and lower churn among small and mid-sized clients [9][10] Q&A Session Summary Question: Client response to agentic products and CTV growth opportunities - Management highlighted three opportunities in agentic products, including audience agents and campaign agents, aimed at simplifying audience generation and campaign management [31][32] - For CTV, investments are being made in supply-side integrations and demand-side tactics to enhance performance and audience acquisition [35][36] Question: Partnership with AI platforms and its impact on e-commerce - Management sees monetization strategies for AI platforms leaning towards native advertising solutions, with a focus on improving product-oriented responses through API data feeds [39][40] Question: Google partnership and its implications - The partnership with Google allows retailers to capture brand search budgets traditionally outside retail media, with an expected significant addressable spend of $172 billion [44][46] Question: Retail media trends and new client ramp-up - Management noted that most Q3 activity was related to existing clients, with new wins like DoorDash starting to ramp up [53][54] Question: Adjusted EBITDA beat and re-domicile implications - The adjusted EBITDA beat was attributed to operational leverage and reduced bad debt reserves, with no material costs expected from the re-domicile [57][59] Question: Investments for AI products and retail media headwinds - Management indicated that investments for AI products are within normal ranges, with a focus on scaling existing tools and partnerships [60][63]

Financial Data and Key Metrics Changes - The company reported adjusted operating income of $3.5 billion and adjusted earnings per share (EPS) of $1.60 for the third quarter, with a 36% increase in adjusted operating income and a nearly 47% increase in adjusted EPS year-over-year [4][15] - Revenues reached nearly $103 billion, marking an 8% increase compared to the prior year quarter [15][24] - The full-year 2025 adjusted EPS guidance was raised to a range of $6.55 to $6.65, up from the previous range of $6.30 to $6.40 [4][24] Business Line Data and Key Metrics Changes - In the healthcare benefits segment, revenues were nearly $36 billion, up over 9% year-over-year, with a medical benefit ratio of 92.8%, a decrease of 240 basis points from the prior year [15][16] - The health services segment generated revenues of over $49 billion, an increase of over 11% year-over-year, although adjusted operating income decreased by 7% to approximately $2.1 billion [18][19] - The pharmacy and consumer wellness segment reported revenues of over $36 billion, a nearly 12% increase year-over-year, with same-store pharmacy sales growing nearly 17% [22][24] Market Data and Key Metrics Changes - The company ended the quarter with medical membership of approximately 26.7 million, flat sequentially but down approximately 445,000 members year-over-year [16] - The pharmacy market share grew to approximately 28.9%, reflecting strong operational performance and customer engagement [22][46] Company Strategy and Development Direction - The company is focused on becoming the most trusted healthcare company in America, emphasizing the importance of diversified business and strategic investments [4][12] - Aetna's performance is improving, with expectations of continued leadership in Medicare Advantage ratings [5][6] - The company is adapting its healthcare delivery strategy, including a reduction in the growth of Oak Street Health clinics, while maintaining a commitment to value-based care [7][21] Management's Comments on Operating Environment and Future Outlook - Management expressed a disciplined and cautious outlook for 2026, highlighting the importance of executing on commitments and adapting to market changes [5][14] - The company remains optimistic about the future, driven by strong performance across diversified business lines and strategic initiatives [13][30] Other Important Information - A goodwill impairment charge of approximately $5.7 billion was recorded in the healthcare delivery segment due to strategic changes in clinic growth expectations [7][20] - The company is actively working on recontracting efforts and improving financial performance in its healthcare delivery business [21][72] Q&A Session Summary Question: Comments on PBM side and future PBM economics - Management acknowledged headwinds in the PBM sector but emphasized the strength of a diversified company and the ongoing transition to a true cost model [32][34] - The company remains confident in delivering strong earnings and cash flow despite near-term challenges [34][41] Question: Drivers of confidence in PCW growth - Management highlighted strong execution, community pharmacy engagement, and the impact of the Rite Aid acquisition as key drivers for growth in the PCW segment [44][46] Question: Provider liabilities and impact on MBR - Management clarified that the 100 basis points of provider liabilities were related to historical matters and not expected to be a recurring issue [52][54] Question: Recontracting efforts at Oak Street - Management indicated that the focus is on ensuring sustainable agreements with payers and improving the path to profitability for Oak Street Health [71][72]

Financial Data and Key Metrics Changes - The company achieved 4% net sales growth, with 3% organic daily sales growth and 11% growth in adjusted EBITDA compared to the prior year period [4][12]. - Adjusted EBITDA for the quarter increased 11% to $127.5 million, and adjusted EBITDA margin improved 60 basis points to 10.1% due to higher net sales, improved gross margin, and increased SG&A leverage [16][29]. - Net income attributable to the company increased 33% to $59 million due to net sales growth, improved gross margin, and SG&A leverage [28]. Business Line Data and Key Metrics Changes - Organic sales volume grew 2% during the third quarter, with agronomic products and landscaping products both achieving 3% organic daily sales growth [13][26]. - Pricing for landscaping products was up 1%, while agronomic products were flat, reflecting a recovery from previous deflation [66]. - Acquisition sales contributed approximately $13 million or 1% to net sales growth [27]. Market Data and Key Metrics Changes - The company estimates it holds about an 18% share of the $25 billion wholesale landscape products distribution market, indicating significant growth potential [6]. - The residential new construction end market was down during the quarter, particularly in Texas, Florida, Arizona, and California, while the repair and upgrade market showed signs of stabilization [13][55]. - Seven out of nine regions achieved positive organic daily sales growth in the third quarter, despite weaker sales in the Sun Belt states [26]. Company Strategy and Development Direction - The company aims to leverage its scale and resources to deliver superior value to customers and suppliers, focusing on organic growth and acquisitions to fill product lines [7][9]. - The acquisition strategy remains a key focus, with four companies added in 2025, contributing approximately $40 million in trailing 12-month sales [21][38]. - Plans to consolidate or close 15 to 20 branches in 2026 are in place to optimize operations and reduce costs [21][58]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to drive continued performance and growth despite softer end markets heading into 2026 [5][55]. - The outlook for the fourth quarter includes expectations for low single-digit organic daily sales growth, driven by positive pricing and commercial initiatives [57]. - Management noted that while the repair and upgrade market has been down, it appears to be stabilizing, providing a foundation for future growth [56]. Other Important Information - The effective tax rate for the third quarter was 20.4%, a decrease from 26.2% in the prior year period, primarily due to increased excess tax benefits from stock-based compensation [28]. - The company has repurchased approximately 656,000 shares for a total of approximately $78 million at an average price of approximately $118 per share year to date [29][31]. - The company plans to maintain financial strength and flexibility to execute its growth strategy in all market environments [31]. Q&A Session Summary Question: Why is the charge not excluded from adjusted EBITDA guidance? - The company maintains strict guidelines regarding adjusted EBITDA, which primarily reflect acquisitions and adjustments within the first year [65]. Question: What is the pricing outlook for agronomic versus landscape products? - Pricing for landscape products was up 1%, while agronomic products were flat. The expectation for the fourth quarter is a price increase between 1% and 2% [66]. Question: Are there signs of stabilization in the repair and upgrade market? - Management noted that discussions with customers indicate stabilization in the repair and upgrade market, with a more optimistic outlook than three months ago [72]. Question: How does the company plan to manage SG&A in the fourth quarter? - The company expects to achieve good SG&A leverage in the fourth quarter, with continued focus on productivity improvements [74]. Question: What is the company's approach to acquisitions moving forward? - The company expects to see a higher number of acquisitions in 2026 compared to 2025, focusing on well-run companies rather than turnaround opportunities [92].

Financial Data and Key Metrics Changes - For the third quarter, net sales decreased by 3%, and in local currency, excluding the Kichler divestiture, sales decreased by 2% [6][11] - Operating profit was $312 million, with an operating profit margin of 16.3% [6][12] - Earnings per share for the quarter was $0.97 [6][12] - Gross margin was 34.6%, impacted by higher tariffs and commodity costs [11][12] - The company anticipates adjusted earnings per share for 2025 to be in the range of $3.90 to $3.95, down from a previous expectation of $3.90 to $4.10 [9][10] Business Segment Data and Key Metrics Changes - Plumbing sales increased by 1% in local currency, driven by favorable pricing, with North American plumbing sales also up by 1% [6][14] - Decorative Architectural segment sales decreased by 12%, or 6% excluding the Kichler divestiture, with operating profit for the segment at $128 million and an operating margin of 19.1% [7][15] - Total paint sales decreased in low single digits, with DIY paint sales down mid-single digits due to soft demand [8][15] Market Data and Key Metrics Changes - International plumbing sales were in line with the prior year in local currency, with growth in many European markets but challenges in China [7][14] - The U.S. and international repair and remodel markets are expected to decrease low single digits in 2025 [19] Company Strategy and Development Direction - The company aims to unlock opportunities through strong execution, strategic investments, and innovative product introductions [5][10] - Focus on maintaining agility in response to macroeconomic uncertainties and rising costs [9][10] - The company is committed to capital deployment, returning $188 million to shareholders through dividends and share repurchases [9][16] Management's Comments on Operating Environment and Future Outlook - Management noted that near-term market conditions remain a headwind, but the company is focused on growing market share and driving long-term shareholder value [6][10] - Structural factors for repair and remodel activity remain strong, including aging housing stock and high home equity levels [10][19] - Management expressed confidence in the company's ability to navigate dynamic environments and deliver long-term value [10][11] Other Important Information - The company generated strong free cash flow and maintained a solid balance sheet, with gross debt to EBITDA at two times [16] - The total annualized cost impact of tariffs is estimated at approximately $270 million, with ongoing efforts to mitigate these costs [18][19] Q&A Session Summary Question: Impact of competitor price increases on paint pricing outlook - Management indicated that they do not expect significant pricing increases for paint as they maintain a price-cost neutrality relationship with The Home Depot [23][24] Question: Long-term impact of tariffs on plumbing margins - Management discussed ongoing efforts to mitigate tariff impacts through sourcing changes and pricing actions, aiming to offset costs and restore margins over time [25][26] Question: Surprises in plumbing margins for Q3 - Management noted that Q3 results were impacted by tariffs, industry softness, and elevated commodity costs, with adjustments in inventory reserves also affecting margins [29][30] Question: Dynamics in builders' hardware business - Management explained that the builders' hardware business faced softness in sales due to shipping timing changes but does not expect significant impacts for the full year [32][33] Question: Inventory reserves and their impact - Management clarified that adjustments in inventory reserves were larger than typical due to market conditions, impacting plumbing segment margins [84][85]

Financial Data and Key Metrics Changes - Third quarter net revenues were $931 million, an increase of more than 2% from $910 million in the year-ago period [15] - Adjusted EBITDA was $168 million compared to $171 million in the year-ago period, reflecting improved results in all operating segments [16] - Adjusted EPS was $0.42 versus $0.41 in the year-ago period, reflecting lower interest costs and tax initiatives [16] Business Line Data and Key Metrics Changes - Retail revenue of $864 million increased 1% compared to the third quarter of 2023, with retail volume growing 1% excluding foam products [15] - Hefty Waste Bags and Reynolds Wrap aluminum foil were highlighted as strong performers, with Hefty Waste Bags year-to-date retail takeaways up 9% [26][10] - The tableware business grew EBITDA despite sales volumes being down 13%, demonstrating increasing success in driving profitability [16][39] Market Data and Key Metrics Changes - The operating environment remains challenging, particularly for low and middle-income consumers facing cost inflation [6][28] - The company noted a shift in consumer behavior, with more affluent consumers tending to be brand loyalists while lower-income demographics are more value-oriented [28][45] Company Strategy and Development Direction - The company is focusing on innovation, revenue growth management, and driving additional share at the customer level [33] - New leadership, including a Chief Commercial Officer and Chief Operations Officer, is expected to enhance growth programs and operational efficiency [8][12] - The company is investing in high-return projects to support growth and drive margin improvements [20] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the continued pressure on consumers and the potential for increased promotional activity in certain categories [28][26] - The company remains confident in its ability to navigate the promotional environment and expects to leverage its U.S.-centric manufacturing footprint as a competitive advantage [6][29] - For the full year, the company expects net revenues to be flat to down 1% compared to 2024, with adjusted EBITDA guidance of $655 million to $665 million [18] Other Important Information - The company is making progress in managing manufacturing, supply chain, and SG&A costs while driving market share [5][12] - The company has implemented pricing actions to recover commodity and tariff impacts, with gross profit showing sequential improvement [16][17] Q&A Session Summary Question: How do you see the setup for the holiday season in terms of promotional intensity and consumer behavior? - Management noted increased promotional activity in waste bags and food bags but feels confident in navigating the promotional environment, with retail takeaways for Hefty Waste Bags up 9% year-to-date [26][28] Question: Why did you flag the risk of retailers shifting store brands to other suppliers? - Management indicated that in a challenging economic climate, retailers may seek to drive value for consumers by shifting to private label business, but expects to win more than lose as a U.S.-centric manufacturer [29] Question: Can you discuss the impact of operational changes on long-term growth? - Management highlighted the addition of key executives aimed at driving growth through innovation and revenue growth management tools, with a focus on optimizing promotional spending [33][60] Question: What is the outlook for the tableware business and foam products? - Management stated that 80% of the decline in tableware was due to foam headwinds, but they are managing profitability effectively despite volume declines [39] Question: How is the Hefty Waste and Storage segment performing in the current environment? - Management noted that innovation and being a performance brand are driving success in the Hefty Waste and Storage segment, with significant volume growth [58]

Financial Data and Key Metrics Changes - Evercore reported record third quarter results with adjusted net revenues exceeding $1 billion, reflecting a 42% year-over-year increase, marking the best third quarter in the company's history [5][16] - Adjusted operating income for the third quarter was $228 million, up 69% year-over-year, with adjusted earnings per share reaching $3.48, a 71% increase compared to the previous year [16] - The adjusted operating margin improved to 21.8%, up from 18.2% in the prior year, indicating a nearly 360 basis point enhancement [16][17] Business Line Data and Key Metrics Changes - Adjusted advisory fees reached $884 million, a record for the third quarter, reflecting a 49% year-over-year increase [16][17] - Underwriting revenues were $44 million, down 1% year-over-year but up 36% sequentially, while commissions and related revenue increased 15% year-over-year to $63 million, marking a record third quarter [18] - Private capital advisory business delivered a record third quarter, with revenues exceeding the full year 2024 total within the first nine months of 2025 [12] Market Data and Key Metrics Changes - The market environment for investment banking has strengthened, with increased M&A activity and capital markets transactions returning after earlier volatility [6][8] - Evercore's European advisory business achieved its best quarter on record, with strong performance across various sectors and products [10][11] - The company advised on four of the 11 largest global M&A transactions as of the end of the quarter, indicating robust market engagement [11] Company Strategy and Development Direction - Evercore is focused on expanding its client coverage and product capabilities while capitalizing on sector and geographic opportunities [5][6] - The company is committed to recruiting exceptional talent, having added 18 partners and one Senior Advisor in 2025, which is its largest partner hiring year [19][31] - The strategic acquisition of Robey Warshaw enhances Evercore's European presence and client service capabilities [9][50] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the investment banking recovery, driven by cyclical and structural factors, with pent-up demand from corporates and sponsors [8][24] - The potential impact of the government shutdown is being monitored, but management believes it will not have a permanent effect on business operations [38][39] - Overall, the company is confident in its ability to deliver strong results moving into 2026, despite geopolitical and macroeconomic uncertainties [24] Other Important Information - The adjusted tax rate for the quarter was 28.7%, slightly down from the previous year [23] - As of September 30, the company had over $2.4 billion in cash and investment securities, with significant share repurchase activity ongoing [23][24] Q&A Session Summary Question: Current environment and trajectory of activity - Management noted a continued strengthening in the market across various sectors, with high engagement levels and backlogs at record highs [27] Question: Comp leverage and future expectations - Management acknowledged the challenge of lowering the compensation ratio while focusing on long-term value creation and client service [31][35] Question: Impact of government shutdown on business - Management indicated that the government shutdown could slow down processes but does not expect a permanent impact on M&A or equity capital markets [38][39] Question: Regulatory environment and deal timelines - Management observed a generally benign regulatory environment, with expectations of a loosening of regulatory scrutiny [42] Question: Impact of recent bank losses on client hesitance - Management stated that recent bank losses are viewed as isolated incidents and are not broadly impacting market confidence [44] Question: Outlook for DCM business in Q4 - Management expressed optimism about a strengthening pipeline and significant deals lining up, despite potential slowdowns due to the government shutdown [46][47] Question: European market environment and white space - Management highlighted a record quarter in Europe and significant growth opportunities as the company expands its coverage [50][52]

Financial Data and Key Metrics Changes - The company achieved its first quarter of profitable goals since its IPO, reporting a positive adjusted EBITDA of $3.1 million, which is $8.2 million higher than the same quarter last year [4][24][30] - Revenue grew by 7.1% year-over-year and 3.8% on a constant currency basis, with volume growth of 6.6% partially offset by a 2.8% decline in price mix [24][26] - Gross margin remained flat at 29.8% compared to the previous year, with improvements in absorption and supply chain efficiencies contributing to a 60 basis point increase [24][25] Business Line Data and Key Metrics Changes - The Europe and International segment saw a revenue increase of 12%, driven by strong volume growth of 8.4%, resulting in an EBITDA margin of 18%, which is 700 basis points higher than last year [10][26] - North America experienced a revenue decline of 10.1%, primarily due to a change in sourcing strategy at a large customer, with adjusted EBITDA declining by $4.5 million [26][30] - Greater China reported a constant currency revenue growth of 28.7%, exceeding expectations, with strong performance in both food service and retail channels [26][30] Market Data and Key Metrics Changes - The food service channel in Europe and International grew by 28% year-on-year, while retail growth accelerated from 4% to 11% in the third quarter [11][12] - In Germany, food service growth exceeded 45% for five consecutive quarters, contributing to a 70 basis point increase in retail market share for plant-based milk [12][13] - The North American food service business, excluding the largest customer, grew by 11% in the quarter, indicating positive momentum [19][21] Company Strategy and Development Direction - The company is executing a refreshed growth playbook that focuses on driving relevance, attacking barriers to conversion, and increasing availability, which has shown positive results in various markets [6][10] - The strategy includes enhancing customer menus and shelves to appeal to Gen Z consumers, with a focus on flavor and experience [11][15] - The company is committed to maintaining strong cost discipline while pursuing growth opportunities, particularly in the North American market [8][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to achieve sustained profitable growth, citing the successful execution of the growth playbook and positive category momentum [4][6] - The company reaffirmed its 2025 guidance, expecting constant currency revenue growth of approximately flat to 1% and adjusted EBITDA in the range of $5 million to $15 million [8][30] - Management acknowledged ongoing challenges in North America but emphasized the potential for growth as the playbook is fully rolled out [21][22] Other Important Information - The company has made significant improvements in cash flow, with a free cash flow net cash outflow of $5 million, which is $22 million better than the previous year [27] - Recent transactions aimed at improving capital structure are expected to save approximately $5 million in annualized interest expense [28][30] - The company is focused on continuous improvement in supply chain efficiencies and SG&A costs as part of its long-term strategy [56][68] Q&A Session Summary Question: Thoughts on 2026 sales growth considering current headwinds - Management indicated that while it is early to provide specific guidance for 2026, they see solid continuity in Europe and expect gradual progress in North America as one-time headwinds are lapped [33][35] Question: Acceleration of oat milk category growth in Europe - Management attributed the acceleration to the experience and taste strategy, which is driving consumer relevance and category demand [39][40] Question: Effective ways to drive customer trial - The company highlighted its barista market developers' role in creating relevant menu offerings and generating trial through unique product experiences [44][45] Question: Plans for greater household penetration in the U.S. - Management expressed confidence in driving strong growth in the U.S. by leveraging similar consumer trends observed in Europe and focusing on taste and flavor [51][52] Question: Margin evolution in North America - Management noted that while there have been challenges, they expect underlying growth to improve margins as they lap previous headwinds [59][62] Question: Competitive environment in Europe - Management emphasized the growth potential in the oat milk category and the company's focus on value rather than competing on price [63][66]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $60.1 million, reflecting a 23.5% increase compared to Q3 2024 and a 6% sequential increase over Q2 2025 [5][18] - Gross profit for the quarter was $46 million, up from $36.4 million in Q3 2024, resulting in a gross margin of 76.6%, an increase from 74.9% in the same period last year [19] - Net income for the quarter was $0.7 million or $0.01 per share, compared to a net loss of $1.9 million or $0.04 per share in Q3 2024 [22] - Adjusted net income was $6.1 million or $0.12 per share, compared to $3.1 million or $0.07 per share in Q3 2024 [23] Business Line Data and Key Metrics Changes - Strong revenue growth was noted across all nerve repair target markets, including extremities, oromaxillofacial, head and neck, and breast [5][6] - The Avance Nerve Graft was identified as the primary growth driver, with significant adoption in various procedures [6] - Active breast ReSensation programs increased by 7% year-over-year, with 281 surgeons performing procedures in Q3 2025, a 20% increase from Q3 2024 [11] Market Data and Key Metrics Changes - Approximately 64% of revenue growth was driven by high-potential accounts, slightly below the target of 66% [7] - Coverage for nerve repair using synthetic conduits or allografts expanded to an estimated 18.1 million additional lives year-to-date, with commercial payer coverage exceeding 64% [15] Company Strategy and Development Direction - The company aims to optimize business models based on experience and maintain growth consistent with strategic plan guidance [5] - Continued focus on expanding presence in high-potential accounts to drive consistent customer creation and algorithm adoption [7] - The company is on track to complete a level one study protocol for implant-based neurotization and advance clinical research initiatives [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to complete the Biologics License Application (BLA) for Avance Nerve Graft by December 5, 2025, which is expected to secure market exclusivity [17] - The company anticipates that the BLA approval will enhance market development efforts and support coverage expansion [77] Other Important Information - The company raised its revenue growth guidance for 2025 to at least 19%, expecting revenue of at least $222.8 million [24] - Operating expenses increased to $44.1 million, but as a percentage of revenue, they decreased, indicating improved operating leverage [21] Q&A Session Summary Question: Insights on Q4 revenue expectations and case stock sales program impact - Management indicated that the $1.6 million revenue increase in Q3 was related to the transition from the case stock program and advised excluding this from Q4 models [28] Question: Comments on BLA labeling expectations - Management confirmed that discussions regarding labeling are ongoing, but no definitive insights were available [33] Question: Coverage expansion trajectory before BLA approval - The increase in commercially covered lives was attributed to refined data tracking, with ongoing engagement with national payers expected [38] Question: Future steps for targeting the prostate market - The company plans to evaluate outcomes from initial clinical trials before determining future investments in the prostate market [58] Question: Impact of BLA on market development efforts - Management noted that BLA approval would positively support market development but cautioned against expecting immediate widespread adoption [77]

Financial Data and Key Metrics Changes - Total adjusted revenue for Q3 2025 grew 1% to $4.9 billion, while adjusted operating income decreased 7% to $1.8 billion, resulting in an adjusted operating margin of 37%, a decrease of 320 basis points [36][37] - Year-to-date adjusted revenue grew 5% to $14.9 billion, and adjusted operating income grew 5% to $5.7 billion, maintaining an adjusted operating margin of 38.2% [36][37] - Adjusted EPS for Q3 was $2.04, down 11% from $2.30 in the prior year [37] Business Line Data and Key Metrics Changes - Merchant Solutions segment organic revenue growth was 5% for the quarter and 7% year-to-date, with adjusted revenue growth also at 5% [39] - Financial Solutions segment organic revenue declined 3% in Q3 but grew 3% year-to-date, negatively impacted by lower periodic license revenue [43][44] - Clover revenue grew 26% in Q3, with GPV growth of 8% reported, and 11% excluding the 2023-2024 gateway conversion [40][18] Market Data and Key Metrics Changes - Argentina contributed significantly to organic growth, with a 257% growth in 2023 and 329% in 2024, impacting overall organic growth rates [9][10] - Excluding Argentina, the company's overall organic revenue growth rate was in the mid-single digits for both 2023 and 2024 [10][12] Company Strategy and Development Direction - The company is shifting its strategic focus to prioritize sustainable, client-focused opportunities, which may negatively impact near-term results but is expected to position the company for predictable growth [4][6] - The "One Fiserv" action plan includes investments in client-first operations, Clover platform enhancements, and operational excellence through AI [22][24] - The company aims to return to consistent mid-single-digit revenue growth and double-digit adjusted EPS growth starting in 2027 [33][21] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the need to reset growth and margin targets due to various factors, including slowing growth in Argentina and the impacts of deferred investments [9][12] - The company remains confident in its assets and growth opportunities, emphasizing that challenges are largely self-inflicted and addressable [14][15] - Future guidance for 2026 is expected to reflect a critical investment and transition year, with organic revenue growth anticipated in the low single digits [21][22] Other Important Information - The company announced several leadership changes, including new Co-Presidents and a new CFO, to drive the strategic initiatives forward [26][30] - Three acquisitions were made during the quarter to enhance client service and expand capabilities in stablecoin and digital currency [46][47] Q&A Session Summary Question: How long was Fiserv over earning with deferred investments and short-term initiatives? - Management indicated that a rigorous analysis was conducted over the past six months, revealing that the company has a solid foundation and growth opportunities, with a clear path to mid-single-digit growth [50][54] Question: What changed in the Financial Solutions segment's growth trajectory? - Management noted that while the segment faced challenges, it remains fundamentally strong, with ongoing investments aimed at improving execution and customer service [68][75] Question: Is Clover's 10% revenue growth for Q4 a decent proxy for next year? - Management expressed confidence in Clover's competitive positioning and highlighted ongoing investments in vertical and horizontal expansion, indicating strong growth potential [79][78]